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THEmajor requirement for the investigation of the physical and chemical
properties of the Rous No. I sarcoma agent is a source of
"purified
" agent of a
uniformly high infectivity, and which may be stored without loss of thisactivity,
since it is not always convenient to compress the investigation to within the
relatively short period in which the purified agent is stable in vitro. This paper
describes a method for the production of concentrates of the vir'us in a form
suitable for storage, and the storage problem itself is considered in the
following paper.
A variety of chemical and physical methods have hitherto been used for
separating and concentrating the agent from biologically-inactive tumourprotein
and nucleoproteins.
Claude (1935a) found that such contaminants could be removed byadsorption
,on to freshlv prepared aluminium bvdroxide gel, and the carbohydrate contami-
nant by precipitation with gelatin. The agent was not directly affected, and a
-combined chemical fractionation and dialysis gave a 25-fold concentration in
-terms ofdry weight (Claude, 1935b).
This method was also investigated by Dmochowski (1948b), who recorded a
50 per cent increase in the activity of the agent compared with the startino,C5
filtrate.
Shemin, Sproul and Jobling (1940), and Shemin and Sproul (1942) precipi-
tated the agent from filtrates by addition ofpapain or of histone. The papain-
agent complex (containing 50 to 70 per cent papain) was found to be at least as
active as the original filtrate. The papain could be removed by fractional centri-
fugation after dissociation of the complex in salt solution. Amounts of agent
corresponding to as little as 7 X 10-7mg. nitrogen (the range was 1-3 X 10-3 Mg.
to 7 X 10-7 Mg.) were found to be infective.
Concentration of the agent by centrifugation was first described by Leding-
ham and Gye in 1935 and fractional centrifugation methods have since been
widely used (McIntosh, 1935 ; Amies, 1937 ; Claude, 1937, 1938, 1939, 1940 ;
Claude and Rothen, 1940; Pollard, 1938, 1939; Stern and Duran-Reynals,
1939; Dmochowski, 1948a). Claude (1938, 1939) isolated a fraction correspond-
ing to less than 3-5 per cent of the dry weight of the original extract which, in
amounts corresponding to 4-0 X 10-10 mg. N, produced tumours in 13 to 17 days
after subcutaneous inoculation into fowls. There are two difficulties in the
separation and concentration of the agent bv fractional centrifugation: (a) the
viscosity of the initial tumour extract-which contains a mucoprotein, and (b)
the tendency of the agent to aggregate, and to adsorb to tissue components.
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Pollard (1939) and Amies and Carr (1939) were able to overcome the first
difficulty by precipitat-ing the agent from a clarified extract by adjusting the pH
to 5.0 to 5-5. The isoelectric point of the purified agent is 3-5, but tumour
extracts deposit a mucoprotein at pH 5-0, which takes down the agent with it.
The aggregated agent, etc., was then further concentrated by a low-speed centri-
fugation procedure. The aggregates were.broken down by tryptic digestion at
pH 8-8 to 9-0 and the released agent further
" purified
" by fractional centrifu-
gation.
Alternatively, the'mucoprotein may behydrolysedby incubation ofthe extract
-with hyaluronidase, which has no deleterious effect upon the agent (Siturm, and
Duran-Reynals, 1932 ; Shemin and Sproul, 1942). The agent may then be
deposited directly from the non-viscous extract.
Bryan, Riley, Deihl and Voorhees (1947) have avoided this difficulty by the
simple, but uneconomical, procedure ofrejecting the first, viscous extract.
A further method which has been claimed to apply to the purification ofsmall
arrLounts ofagent is that ofchromatography on Celite (Riley, 1948). The agent
is strongly adsorbed to Celite from physiological salt solution, but may be eluted
withverydilute(O-001m)saltsolution. Intermsoftheratio,biologicalactivity:
nitrogen content, a 3- to 7-fold enrichment was obtained from apartially'-purified
tumour extract. Three of the above methods, papain precipitation, fractional
centrifugation after precipitation at pH 5-0 and direct deposition after treatment
of the initial extract with hyaluronidase, have been reinvestigated from the
point of view of the preparation oflarge quantities of agent in a form suitable
for storage. A further method, methanol precipitation, hitherto applied to a
number of other animal viruses, has also been investigated.
Cox, van der Scheer, Aiston and Bohnel (1947) found that influenza virus
(from aRantoic fluid) could be precipitated in active form from suspensions in
phosphate buffer atpH 7-0 to 8-0by addition ofmethanol to a final concentration
of 15 to 30 per cent. The method was applied to psittacosis virus purification
by Wagner, Golub and Andrew (1948) and to mouse poliomyehtis by Brunfield,
Stulberg and Halvorson (1948). Fischer (1949) found, however, that rabbit
papilloma virus was reduced in titre after suchprecipitation andMoyer, Sharpless,
Davies, Winfield and Cox (1950) have recently stressed the necessity for using
0-3 m biiffer solutions for the extraction of influenza virus from the methanol
precipitates.
MATERIALS AND METHODS.
Tumour.
The Rous No. 1 tumour used was grown throughout in 6-week-old Brown
Leghorn fowls from Dr. Greenwood's Edinburgh flock. Only fast-growing
tumours, 20 to 30 days old were used. Such tumours are known to contain
similar amounts ofvirus with little or no associatedinhibitory material.
1: 10,000 HCN.-One ml. m KCN was added to 8 ml. water and neutralized to
phenol red with N HCI ; I ml. added to 1 1. buffer gives a final concentration of
1:10,000.
Buffers.-In'the pH range 2-2 to 9-0, Mcllvaine's (1921) phosphate-citric acid
buffer has been used. The buffer components are 0-2 m Na2HP04 and 0-I m
citric acid. Ofeach buffer 50 ml. was diluted before use to I 1. (0-005 m buffer).
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Tryp-sin.-Crystalline trypsin (Armour Laboratories) containing 50 per cent
magnesium sulphate.
Hyaluronidase.-Fresh rat testes werehomogenized (Waring
" blendor ") with
10 vol. water. The suspension was roughly filtered through surgical gauze and
frozen-dried in 10 ml. aliquots in 25 ml. McCartney bottles. The contents of
each bottle were reconstituted before use by the addition of 10 ml. water.
Papain.-British Driig Houses, Ltd.
-Centrifuge,3.
The Rous agent becomes progressively more thermolabile as purification
proceeds. Centrifuge B was used in a cold-room at O' C., and C was adjusted to
a chamber temperatuiffe of O' C. The Sharples centrifuge (A) was cooled with
running tap water only. The centrifugal procedures used are listed below and
will be referred to in the rest of the paper by such abbreviations as (A, i).
A. Sharples air-driven supercentrifuge, stainles-3 steel bowls.-(i) Clarifica-
tion; clarifier bowl; maximum flow rate at 25,000 r.p.m. (ii) Deposition at
pH 5-0: Same bowl and conditions as (i). (iii) Deposition at pH 7-0. The same
bowl as (i) and (ii), but 30 ml./minute flow at 48,000 r.p.m.
B. Serval angle, centrifuge, Type SS.1, lusteroid tubes.-(i) Clarification; 5000
r.p.m. (3000g.) for 20 minutes. (ii) Deposition at pH 7-0; 11,000 r.p.m. (14,400
g.) for 55 minutes.
C. International refrigerated centrifuge, Type PR-I.-High speed attachment
andangle head No. 296 ; lusteroid tubes. (i) Clarification; 5000 r.p.m. (2000g.) for 18 minutes. (ii) Deposition; 15,000 r.p.m. (17,000 g.) for 57 minutes.
WariW blendor efficiency.
Doubt has frequently been expressed, usuaRy without supporting evidence,
-concerning the use ofthe Waring
" blendor
" for the maceration oftissues for the
liberation of enzymes and viruses. It would obviously be tiresome to
" mince
"
half-kilogramme batches oftumour with the
" conventional
" scissors and accord-
ingly the efficiency of the Waring
" blendor
" was tested in the following way. Tumours from two fowls were removed and smaRsamples, totaRingabout 5 g., taken. The bulk of the tumour was extracted in the Waring
" blendor
" with
10 volumes of water containing 1:10,000 HCN, and the small sample "minced
with scissors
" and extracted into a similar medium. Suitable dilutions ofthese
extracts were injected into fowls. The Waring
" blendor
" extract gave tumours
at a dilution corresponding to 10-5g. of tumour, while the other failed to give
tumours at an equivalentof 10-4 9-
I. Precipitation with Papain.
In the Waring
" blendor
" 44 g. fresh tumour tissue was disintegrated with
440 ml. 0.005 m buffer at pH 7-2 containing hyaluronidase and 1:10,000 TICN.
The tissue suspension was clarified (B, i) and the agent deposited from the super-
natant (B, ii). The combined pellets were resuspended in 25 ml. water by gentle pipetting and the suspension clarified (B, i). Aliquots of I ml. of the supemate
were added to (a) 5 ml. water (control), (b) 5 ml. papain solution (Shemin and
Jobling, 1940; Shemin and Sproul, 1942) and (c) 5 ml. 0-1 per cent trypsin (B.D.H.). The mixtures were then incubated at 37' C. for I hour. Tube (b)86 J. G. CARR AND R. J. C. HARRIS
developed a precipitate which was deposited. The control suspension (a) was'
assayed comparatively against (b)-resuspended papain-agent complex, etc., (b)
-supematant and (c). The assay showed that (b) deposit and (c) were devoid of
any activity, (b) supematant was weakly active and (a) control was highly active
at I . In view ofthe results obtained by Pirie in 1933, the inactivation
by crude commercial trypsin was not unexpected, but the result with (b) was.
II. Precipitation wilth Metha-nol.
(1) A fresh tumour tissue suspension was prepared bv disinte ration in the
Waring
"' blendor
" with 10 vol. of water containing 1:10,000 HCN. This sus-
pension was clarified (A, i). The supernatant was then cooled to 12' C. and
methanolic buffer solutions prepared, and cooled to 5' C. These buffers con-
tained (a) 40 per cent methancil, (b) 50 per cent methanol and (c) 60 per cent.
methanolrespectively in 0-005 m buffer. Equal volumes of (a), (b), (c) or buffer
(d)-control, were added to volumes of the supernatant. The four groups were
stored at O' to 2' C. for 2 hours and then clarified (B, i). The supernatants (Sa,
etc.) were set aside for assay and the deposits resuspended in'an equal volume of
0-005 m buffer and re-clarified. These supernatants (Saa, etc.) were also assayed.
Virus activity was retained in Sd, Sa and Sc. Activity was also found in Saa.
and, doubtfully, in Sbb ; Sec had no activity.
It was concluded that the precipitation with methanol was incomplete even
at a concentration of 30 per cent and that methanol concentrations greater than
25 per cent tended to attenuate any precipitated agent.
(2) Method I was followed for the preparation of the initial clarified tumour
extract. The control virus suspension was prepared bv deposition from the
clarified extract at pH 5-0 (A, ii), followed by resuspension of the deposit at pH
7-0. Anequal volume of 50 per cent methanolic buffer was added under the same
conditions as Method 1 and the resuspended deposit assayed against the extract.
The assay showed that the alcohol-deposited agent had only I per cent of the
activity of the control suspension.
(3) A similar clarified extract was prepared, cooled to O' C. and the conditions
of Method 2 again followed. Larger volumes were used and the alcohol-precipi-
tated agent was-deposited at low speed (A, i). The deposit was resuspended in
0-005 m buffer atpH 7-2, clarified (B, i) and theagent in thesupernatantdeposited
(B, ii). The pellet was finaRy resuspended in 0-005 m buffer, pH 7-2, adjusted
in concentration to the equivalent of I g. tumour tissue/ml. (10'-see Biological
Assay) and assaved against the extract, similarly adjusted. The control con-
tained >10,000 minimal infective doses per ml., whereas the alcohol deposited
agent contained <1000 m.i.d. per ml.
III. De osition after Precipitation at pH 5-0.
A 10 per cent fresh tumour tissue suspension was prepared in the usual way,
but with the omission ofhyaluronidase. The suspension was clarified (A, i) and
deposited (A, ii) after adjustment to pH 5-0 by addition of an equal volume of
0-005 m buffer at pH 5-0.
Fractional centrifugation.
The deposit from (A, ii) was resuspended in 0-005 m buffer at pH 7-0 (v/w of
original tumour tissue taken) and clarified (B, i). The supernatant, 8 (Fig. 1)PREPARATION OF ROUS NO. 1 SARCOMA AGENT 87
was decanted and thedeposit D, re-extracted with a similar volume of the same
buffer and re-clarified (B, i) giving a deposit D3and a supernatant, S3'
The agent, etc., of supernatant S was deposited (B, ii). The supernatant
(Sl) was re ected and the agent deposit (D1) re-extracted with 0-005 m buffer at
pH 5-0 (25 per cent v/w original weight tumour) and re-clarified (B, i). This
supernatant (SO was adjusted to pH 7-0, and deposit (D2) resuspended in the
same'volume of 0-005 m buffer atpH 7-0. D21 S2 andS,, wereassaye-d in the usual
way. D2 contained more than 10,000 m.i.d./ml.; 83, not more than 1000 andS2
not more than I00 m.i.d./ml. (Fig. 1).
Deposit. rejectecl pH 7-0
S D
pH 7-0
DI S3
pH 5-0 10-3
D2
>. 10-2 >10-4
FiG. 1.
These results show that this method, although used successfuRy by PoHard
(1939) and by Amies and Carr (1939), had certain limitations. With an initial
volume oftumour extract of 5 litres (from 500 g. tumour) the volumes of suspen-
sion to be centrifuged at the pH 5 deposition stage were very large. One of the
major difficulties with the Rous agent is itstendency to aggregate andprocedures
whichuttempt to isolate it by aggregation ought, therefore, to be avoided. The
loss by aggregation is well illustrated in Fig. 1, since S3 !L-- D2 in titre (where S3
derives from the second extract of the material aggregated at pH 5-0 for deposi-
tion). Moreover, deposit D, lost agent after extraction with 0-005 m buffer at
pH 5-0 (S2 assayed at ..10-2) and the efficiency of the initial deposition process
was thereby caRed into question.
The main reason why di'rect deposition of the agent from a clarified extract
has not hitherto been attempted on a large scale is simply that suitable centri-
fuges have not been available. The air-driven Sharples supereentrifuge with a
maximum speed of rotation of 50,000 r.p.m. (62,000 g.) was used by Stanley in
1945 for the concentration ofinfluenza virus for vaccine production. Under such
conditions the Rous agent may be deposited from a continuously-flowing non-
viscous (i.e. hyaluronidase-treated) extract.
IV. Direct Deposition with the Sharples Centrifuge.
1. Boundary phenomenon.
In the Waring
" blendor
" 145 g. fresh tumour tissue was disintegrated with
10 volumes of 0-005 m phosphate buffer at pH 7-2 containing hyaluronidase and88 J. G. CARR AND R. J. C. HARRIS
1:10,000 HC.N. The suspension was clarified (A, i) and the virus deposited from
thesupematant (A, iii). Fordeposition ofthe virus the stainless- steelcentrifuge
bowl was invariably lined with cell'ophane (7/1000 in.) which may (a) be readily
withdrawn and which (b) minimizes contact ofthe virus with metals.
When unrolled this
" liner
" invariably showed a boundary, the distance of
which from the bottom of the bowl, varied with the rate of flow of the virus
suspension through the centrifuge. In terms of total nitrogen distribution, the
deposit was uniformly distributed above and below the boundary, although the
virus content ofthetop and bottom fractions differedconsiderably. The
" liner
was therefore divided at the boundary and the deposits removed and separately
resuspended in 0-01 m buffer at pH 7-2 (DBandDT). A few mg. per cent crystal-
line trypsin was added to each, the suspensions incubated at room temperature
for 40 minutes and the virus re-deposited (A, iii) (SB, ST-supernatants and DBj,
DT,-deposits). The separate fractions were analysed for total nitrogen. In this
second deposition procedure neither fraction gave a boundary indicating that the
material below the initialboundary was largely trypsin-digestible.
The results may be tabulated.
TABLE 1.
Fraction. N, mg. N, per cent Comparative
total N. assay.
Bottom.
DB 49-5 51.5
SB 43-2 45-0
DB., 6- 3 6.5 10-2
Top.
DT 47-0 48-5
ST 21-4 22-2
DT1 25-5 26-4 10-3
Trypsindigestion removed 87 5 per cent ofthenitrogen ofthebottomfraction,
but only 45-5 per cent of that of the top fraction. Overall 67 per cent of the
total nitrogen was thus removed. The virus concentrates (DB,+DT,) con-
tained 31-8 mg. nitrogen (33 per cent of the total nitrogen) of which 80 per cent
(25-5 mg.) was recovered from the top fraction. The fractionsDB, and DT, were
assayed comparatively at 10-11 10-2 and 10-3 , and the figures recorded do not
refer to the m.i.d.
2. Nitrogen di8tribution after tryp8in treatment.
In the Waring
" blendor
" 520 g. fresh tumour tissue was disintegrated with
10 volumes of 0-005 m phosphate buffer at pH 7-2 containing 1:10,000 HCN-but
withouthyaluronidase-and thesuspension clarified (A, i). Four litres ofextract
wasobtained which was then treated with clarified (C, i) rat testes extractandio
2 1. ofwhich was added c. 0-5 mg. per cent crystalline trypsin. The non-tryp-
sinized half (X) was deposited (A, iii), the
" liner
" removed and divided at the
boundary. The top (XT) fraction was resuspended in 0-005 m buffer, pH 7-2
and clarified (B, i). The supematant from this (XTS) was assayed in the usual
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The trypsinized half (Y) was first re-clarified (A, i) to remove a slight deposit
which hadformed, and theagent thendeposited (A, iii). No boundary was found
,on the
" liner
" and the totaldeposit (YD) wasresuspended in buffer and clarified
(B, i). The supematant (YDS) was assayed. Fractions were analysed for total
.nitrogen (Table II).
TABLE II.
Fraction. N, mg. N, per cent
total N.
X (no trypsin) 1310 100
Total deposit on liner 208 16
XTS 13- 8- 1.05
Y (trypsin) 1310 100
Total deposit on liner 81-5 6- 2
YDS 22-2 1- 7
The virus-containing fractions, XTS and YDS, contained a total of 36 mg. nitrogen (1-375 per cent total nitrogen in original clarified tumour extract).
Assays showed that the tr.ypsin-treated fraction (YDS) not only contained
-rnore nitrogen than the non-trypsinized XTS, but that, at a clilutionofIO-6'YDS
-was more active than XTS. The trypsin removed again some 61 per cent ofthe
-nitrogen of the treated fraction.
'3. Efficiency offractional centrifugation.
A
" liner
" deposit was prepared from II0 g. fresh tumour tissue in the usual
-manner (p. 88).
Thedeposit(D1) wasresuspendedin 100ml,0-005 mbuffer,pH 7-0, andtreated
-with crystallinetrypsin for I hour at room temperature. (a) Thesuspension was
-then clarified (B, i), the deposit (D2) discarded and (b) the virus deposited (B, ii) from the decanted supernatant (SjL). The supernatant (SO from this deposition
-was discarded and thedeposit (D3)resuspended in 60 ml. buffer and (c) re-clarified
(C, i). This deposit (D4)was rejected and virus again (d) deposited (C, ii) from
-the supernatant (S.). The supematant (S4) from this. deposition was assayed. The deposit (D,) was resuspended in 30 ml. buffer and (e) re-clarified (C, i). The
,deposit (D6)was negligible. The su ernatant (SO was assayed in the usual wav.
Results :
.1
S5 contained more thanlo7m.i.d. per ml.
S4 contained not more than 10 m.i.d. per ml.
(Tumoursin 2 out of4fowls atdilution 10-1.)
The separation is shownschematically in Fig. 2.
The results show that, although virus losses may be expected to occur by -aggregation and removal in clarification procedures (into deposits such as D2and D4) no loss occurs in thedepositionstages, such as (d), since the amount ofresidual
virus in S4 was infinitesimal.
4. Standard procedure.
This procedure has been adopted for routine preparation of a virus concen-
trate suitable for preservation by freeze-drying.90 J. G. CARR AND R. J. C. HARRIS
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(b)
S2 3
(C)
-
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(d)
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(e)
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FIG. 2.
A
" liner
"deposit wasprepared from 375 or. fresli tumour tissue by the method
described on p. 88.
The
" liner
" was removed and the total deposit (D.,) resuspended in 375 ml.
0-005 m phosphate buffer at pH 7-5 to 8-0 containing a few mg. per cent crystal-
line trypsin. The suspension was incubated at room temperature for I hour,
clarified (B, i) giving a deposit D2 (rejected) and a supematant (SO from which
the virus was deposited (B, iii). The s'upematant (S.) from this deposition was
rejected and the deposit (D.) resuspended in 300 ml. Lemco broth, distributed
into McCartney bottles in 10 ml. ahquots and frozen-dried. Each fraction was
assayed for protein nitrogen (insoluble in cold, 5 per cent trichloracetic acid) and, total nitrogen.
The results are given in Table III.
TABLE III.
Protein N, mg. Non-protein
N, mg.
1760 464
308 14
260 62
184 62
76
140 62
44
Protein N as per
cent total N.
79
14
11- 7
8-25
3-4
6-3
2-0
Fraction.
Clarified tumour
extract
Di
D., (trypsinized)
S2
D2
.q-3
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The results show that 44 mg. of the 308 mg. protein-nitrogen of the original
Sharples deposit appeared as
" virus concentrate
" (D,3). Of the remaining 264
mg., 48 mg. appeared as acid-soluble nitrogen after trypsinization, 76 mg. was
discarded as aggregated material (D2) and 140 mg. was not sedimented under con-
ditions in which the virus was deposited (i.e. this material waspartiallvdegraded
by the trvpsin). In this experiment 188 mg. N out of 308 mg. was removed
as a result of the enzyme treatment. This amount (61 per cent) is in good
agreement with the results ofIV, 1 (67 per cent) and IV, 2 (61 per cent).
DISCUSSION.
The results of the first three methods investigated show that in our hands
neither papain precipitation nor methanol precipitation gave encouraging
e-vidence of the concentration of active agent. Deposition by pH adjustment to
pH 5-0 gave material with a high titre but had two major disadvantages in that
large volumes of suspension had to be handled, and the agent, once aggregated,
was very difficult to redisperse.
Investigation of the direct deposition of the agent bv high-speed continuous
-flowcentrifugation showed that the bulk oftheheavyprotein-containing material
which sedimented more rapidly could be hydrolysed by short treatment with
purified (crystalline) trypsin at room temperature at pH 8-0 to 9-0. Over 60
per cent of the nitrogen of the total deposit was rendered non-sedimentable by
this treatment and the acti-vity of the agent was apparently unimpaired. Virus
tc concentrates
" thus prepared contained some J-7 to 2-0 per cent ofthe nitrogen
of the original extract and had titres greater than 1,000,000 m.i.d. per iul./g.
tumour.
Such comparatively
" unpurified
" material as YDS (Table II) had an m.i.d.
ofless than 1 x 10-11 mg. N-ten times as good, in fact, as the material obtained
by Shemin and Jobfing (1940) by papain precipitation.
It is difficult to express the
" purity of a virus preparation except in terms
of a large number of factors, but the concentrates
" obtained by the above
methods have been freed of more than 98 per cent of non-virus nitrogen, may
readily be stored (Carr and Harris, 1951), recovered and subjected to further
procedures designed to increase the physical, chemical and biological homo-
geneity of the agent.
Thephysical and chemical behaviour ofthe agent wiR form the substance of a
later communication.
Biological assay.
The various methods which have been used for the determination of the
tumour-producing activity of Rous agent preparations faR essentially into two
groups. In the first group serial dilutions are made and injected into fowls.
The highest dilution at which a tumour is roduced gives a "minimal infective
dose
" (m.i.d.). In the second group, the virus suspension of unknown titre is
inoculated into a fowl, together with a standard virus suspension of known titre.
The titres are compared either by the relative sizes of the tumours ultimately
produced or by the time elapsing before detectable tumours arise.
This second group ofmethods, although useful, no doubt, in certain types of
work, was avoided by us. There was no a prtort reason for assuming that a92 J. G. CARR AND R. J. C. HARRIS
constant standard could be obtained or that the subsequent comparison would
be unaffectedby such factors as the season ofthe year orthe nature ofthe medium
in which the virus wassuspended. The first group (" limiting dilution
" methods)
had, also, theadvantage ofgiving some degree ofabsolute measure corresponding
to the actual number oftumour-producing particles.
Two injection routines have been favoured by prev-ious workers; either the
intradermal or the intramuscular. The former allows several different dilutions
to be tested in the same bird, but accurate localization oftheinjection is rendered
difficult by the paper-thin structure of the avian skin. Moreover, the frequent
occurrence of resistant fowls necessitates replication ofthe tests. Intramuscular
injections involve a more readily standardized reaction site, but 6-week-old birds
frequently show a variable and unpredictable resistance to the virus.
Such resistant birds may not react to 1000 times the virus dose which will
produce tumours in susceptible birds, and if the end-point,(m.i.d.) is dependent,
as may be shown, upon a Poisson distribution of virus particles, then a large
number of 6-week-old fowls would be required for an accurate assay.
It is inconvenient to use large numbers of birds of this age for a single assay
and for such reasons the use ofembryos or ofday-old chicks, which may readily
be obtained in large numbers, was investigated. Embryos were found to be
less convenient than day-old chicks, since a tumour is only produced in the
embryo, when (andwhere) a deliberateinj'ury is inflicted at the time ofinoculation
(i.e. pock-count methods cannot be used). Moreover, the separate injection of
each embryo is a laborious task.
The day-old chick is known to show less virus resistance than older birds
(Carr, 1943). Such chicks may be used in large numbers, but, since metastasis
to the site ofinjuryproduced by a non-infective, inoculation may occur, only one
test injection in each chick is possible (Carr, 1943).
Preliminary tests on serial decimal dilutions in groups of 50 chicks were
encouraging. False negatives in birds receiving high concentrations ofvirus did
not occur, indicating that the chicks were notmanifesting resistance to the virus.
The nature of the
"tailing-off
" of activity in the high dilutions indicated that
an accurate estimate of the titre could be obtained. Table IV gives examples ofassays from a few ofthe early tests.
TABLE IV.
Dilution.
Experiment r
niimber. 1 x 10-3. 1 X 10-4. 1 X 10-5. 1 X 10-6. 1 X 10-7. 1 x 10-8.
1 3/3 4/4 4/5 0/5 0/5
2 4/4 5/5 6/6 1/7 0/7
3 6/6 2/6 1/5 0/6
4 8/8 3/7 1/7 0/7 0/7 0/7
5 6/6 6/6 1/7 0/7
In the dilution columns of these Tables (IV, V and VI) the numerator of the
fraction shown refers to the number of tumours and the denominator to the
number ofinoculations. All titres are referred back to the wet weight oftumour
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such that I ml. = I g. tumour (I ml. g. equivalent), 10-5 iSthusequivalent to 105
infective doses per g. oforiginal tumour.
Inpractice it was found convenient toinject an inoculum of O-I or 0-2 ml. into
a leg muscle of these chicks (which were aged 2 to 7 days). The tumours begin
to be palpable after about 14 days, and most have appeared at 21 days. The
survivors are killed and examined at 28-days. Sudden deaths in the young birds
as a result of the
"haemorrhagic disease
" described by Milford and Duran-
Reynals (1943) did not occur when the inoculum was given into theleg muscle.
Irregular results were obtained in the assay when the. virus suspension was
obviously aggregated (Table V).' This virus suspension settled out even under
gravity.
TABLE V.
Dilution.
Experiment
number. 2 X 10-5. 2 X 10-6. 2 x 10-1. 2 x 10-11.
6 3/4 5/5 0/2 2/3
It is further obvious that, where the titre of a virus preparation is known
approximately (as it now is for the majority of our frozen-dried preparations),
the serial dilution may begauged more closely and the bulk ofthe 50 chicks used
for the important hmiting dilutions. The methods for this require the normal
statistical treatment and tables for arranging such experiments are given by
Fisher and Yates (1947).
Compari8on of asgay method8in 6-week-old birds and in young chicks.
Several comparisons were made of the titre ofpreparations given by assay in
6-week-old birds and in young chicks. In each test the young chicks were clearly
more sensitive to the virus.
The results are shown in Table VI.
TABLE VI.
Dilution.
Experiment Age of Factor. 10-1. 10-2. 10-3. 10-4. 10-5. 10-6. 10-7. 10-18' number. bird.
f 6 weeks 0-5X 4/4 4/4 1/4 0/4 0/4 0/4 7 _.Chicks 0.2x 6/7 0/6 0/6 0/6
6 weeks 0-5X . 4/4 1/4 0/4 -
-
8 Chicks 0.2x .
- - 2/5 0/7 0/7 0/7
6 weeks 0-5X . 2/3 2/2 2/3 2/2 2/3 2/3 0/2 0/2 9 Chicks 0
- I x . - - 8/8 8/8 5/8 1/8 1/8 0/8
10 6 weeks O-5X . 4/4 4/4 4.4 4/4 4/4 0/4 0/4 0/4
Chicks 0
- I x . - 5/5 2/2 5/5 4/6 1/6 0/5
11 6 weeks 0-5X . 4/4 3/4 0/4 0/4 0/4 0/4 -
Chicks 0-2x 4/4 6 /6 0/6 1/7 0/7 0/7
SUMMARY.
A number of methods for the preparation of
" concentrates
" of Rous agent
have been investigated. Direct deposition of the virus from hyaluronidase-
treated tumour extracts followed by treatment of the deposit with crystalline94 J. G. CARR AND R. J. C. HARRIS
trypsin (which removes more than 60 per cent of the non-virus proteins)
gives a product containing only 2 per cent of the nitrogen of the clarified
tumour extracts, but possessing almost aR the virus activity. The minimal
infective dose ofsuch comparativel crudepreparations is ofthe order of I X 10-8 y
mg. N and, these virus concentrates may readily be stored by freeze-drying. A
biological assay method using very young chicks has beerr developed. These
chicks are found to be more sensitive to the virus than older birds and are
obviously more convenient to handle and maintain.
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